Phase

n/a (18,746)

phase 2 (10,982)

phase 1 (6,924)

phase 3 (5,643)

phase 4 (4,264)

phase 1/phase 2 (3,650)

phase 2/phase 3 (869)

early phase 1 (550)

Funder Type

Other (43,540)

Industry (17,844)

NIH (2,048)

U.S. Fed (440)

Study Type

Interventional (51,636)

Observational (10,945)

Observational [Patient Registry] (1,218)

Expanded Access (73)

Combination-evaluation

Showing 1 - 25 of >10,000

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Lymphedema Arm Trial (BioBridge)

Not yet recruiting

Lymphedema Arm

BioBridge

(no location specified)

Apr 20, 2023

Mood Regulation Trial in Ottignies-Louvain-la-Neuve (Saffron extract, Scutellaria baicalensis extract, Saffron and Scutellaria

Recruiting

Mood Regulation

Saffron extract
+3 more

Ottignies-Louvain-la-Neuve, Belgium

Université Catholique de Louvain, CICN

Nov 17, 2023

Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Aurora (Mirvetuximab Soravtansine, Olaparib)

Not yet recruiting

Ovary Cancer
+2 more

Mirvetuximab Soravtansine
Olaparib

Aurora, Colorado

University of Colorado Hospital

May 30, 2023

Urinary Bladder, Overactive, Urodynamics, Effect of Drug Trial in Taipei (Intradetrusor Botox® (onabotulinumtoxinA) injection,

Recruiting

Urinary Bladder, Overactive
+2 more

Intradetrusor Botox® (onabotulinumtoxinA) injection
Combine Mirabegron and Solifenacin.

Taipei, Taiwan

Mackay Memorial Hospital

Jul 29, 2023

Acne Vulgaris Trial in Uzhhorod (Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule, Topical Adapalene, Benzoyl

Active, not recruiting

Acne Vulgaris

Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule
Topical Adapalene, Benzoyl Peroxide Gel

Uzhhorod, Zakarpattia, Ukraine

TDC PE "Asklepiy"

May 4, 2023

Poly Cystic Ovary Syndrome Trial (Daflon, Combined oral contraceptive, Metformin)

Not yet recruiting

Poly Cystic Ovary Syndrome

Daflon
+2 more

(no location specified)

Oct 9, 2023

Tumors Trial run by the NCI (Nilotinib and Paclitaxel)

Recruiting

Neoplasms

Nilotinib and Paclitaxel

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 19, 2023

Metastatic Breast Cancer Trial (Lasofoxifene in combination with abemaciclib, Fulvestrant in combination with abemaciclib)

Not yet recruiting

Metastatic Breast Cancer

Lasofoxifene in combination with abemaciclib
Fulvestrant in combination with abemaciclib

(no location specified)

Jan 25, 2023

Prostatic Hyperplasia Trial in Banha (Chromax, Sildosin Group, Placebo Group)

Recruiting

Prostatic Hyperplasia

Chromax
+2 more

Banhā, Kalubyia, Egypt

Banha University Hospitals

Nov 9, 2022

Liver and Biliary Cancer Patients Treated With PD-1 Combination

Active, not recruiting

Hepatocellular Carcinoma
Bile Duct Cancer

[68Ga]FAPI PET/CT and [18F]FDG PET/CT

Beijing, China

Department of Nuclear Medicine, Peking Union Medical College Hop

Dec 14, 2022

Safety Issues, Efficacy, Self Trial in Monterrey (low dose nivolumab in combination with AVD)

Recruiting

Safety Issues
Efficacy, Self

low dose nivolumab in combination with AVD

Monterrey, Nuevo Leon, Mexico

Hospital Universitario Dr Jose Eleuterio Gonzalez

Mar 6, 2023

Gastric Disease Trial in Lucknow (Evaluation of gastric visibility following the combination drink of N-acetyle cysteine and

Not yet recruiting

Gastric Disease

Evaluation of gastric visibility following the combination drink of N-acetyle cysteine and simethocone

Lucknow, Uttar Pradesh, India

Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIM

Apr 5, 2023

Periodontal Pocket Trial (silk fibroin, Chlorhexidin, combination of silk fibroin and chlorhexidine)

Not yet recruiting

Periodontal Pocket

silk fibroin
+2 more

(no location specified)

Sep 16, 2023

Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,

Not yet recruiting

Allergic Conjunctivitis

Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
+3 more

Phoenix, Arizona
+2 more

Nov 9, 2022

Cataract, Glaucoma, Ocular Hypertension Trial in Glendale (Bimatoprost Implant System (High Dose), Bimatoprost Implant System

Recruiting

Cataract
+2 more

Bimatoprost Implant System (High Dose)
+4 more

Glendale, Arizona

Arizona Advanced Eye Research Institute

Nov 8, 2023

Seasonal Allergic Conjunctivitis Trial in Andover, Memphis (Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic

Not yet recruiting

Seasonal Allergic Conjunctivitis

Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution
+3 more

Andover, Massachusetts
+1 more

Nov 9, 2022

Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%

Not yet recruiting

Allergic Conjunctivitis

rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution

(no location specified)

Apr 4, 2023

BRAF V600-mutated Lung Carcinoma Treated With Combination of

Completed

Non Small Cell Lung Cancer
BRAF V600 Mutation

Créteil, France
+1 more

Jun 29, 2022

Molar, Third, Third Molar Surgery, Soft Tissue Swelling Trial in Lisbon (Combination of corticosteroid (methylprednisolone -

Recruiting

Molar, Third
+4 more

Combination of corticosteroid (methylprednisolone - Medrol, 16mg Pfizer Laboratories) therapy and non-steroidal anti-inflammatory (Ibuprofen 600mg Mylan) therapy
Non-steroidal anti-inflammatory therapy (Ibuprofen 600mg Mylan)